Hck
Hck inhibitors are compounds that target Hematopoietic Cell Kinase (Hck), a member of the Src family of tyrosine kinases involved in immune response regulation, cell growth, and differentiation. Hck is implicated in various diseases, including leukemia, inflammation, and immune disorders. Inhibitors of Hck are essential for exploring the role of this kinase in disease progression and therapeutic intervention. At CymitQuimica, we provide Hck inhibitors to support your research in immunology, oncology, and signal transduction.
Found 3 products of "Hck"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Hck-IN-1
CAS:Hck-IN-1 selectively inhibits Nef:Hck, IC50: 2.8 μM; >20 μM for Hck alone. Potent HIV-1 Nef antagonist, IC50: 100-300 nM for HIV-1 replication.Formula:C16H11ClN6O3SPurity:99.07%Color and Shape:SolidMolecular weight:402.81Ref: TM-T11538
1mg62.00€5mg128.00€10mg197.00€25mg323.00€50mg469.00€100mg637.00€1mL*10mM (DMSO)141.00€iHCK-37
CAS:iHCK-37 (ASN05260065) is an Hck inhibitor with antitumor activity and blocks HIV-1 replication, used in chronic myelogenous leukemia (CML) research.Formula:C30H32N4O2S2Purity:99.97%Color and Shape:SolidMolecular weight:544.73TL02-59
CAS:TL02-59: Fgr inhibitor (IC50=0.03nM), also targets Lyn (0.1nM), Hck (160nM), halts acute myelogenous leukemia growth.Formula:C32H34F3N5O4Purity:98.77%Color and Shape:SolidMolecular weight:609.64Ref: TM-T13186
1mg49.00€2mg62.00€5mg93.00€10mg133.00€25mg260.00€50mg401.00€100mg557.00€200mg790.00€1mL*10mM (DMSO)111.00€
